Literature DB >> 6988220

Everything the pediatrician ever wanted to know about HLA but was afraid to ask.

E Passarge, E Valentine-Thon.   

Abstract

Following a description of the genetic aspects of the human histocompatibility antigens system HLA and its principle typing methods, this paper reviews the relationship between HLA antigens, transplantation immunology and certain diseases. In particular, the role of the lymphocyte-defined antigens of the HLA-D system is emphasized on the basis of a special typing method, the PLT test, used in our laboratory. Aside from its necessity in bone marrow and kidney transplantation, HLA typing can be used as an additional diagnostic or prognostic tool for certain diseases. Among the pediatric age group, this includes rheumatic fever and other rheumatic diseases, insulin-dependent juvenile diabetes mellitus, some forms of Addison's disease, thyrotoxicosis, myasthenia gravis, celiac disease, and some complement deficiency disorders. Close linkage of the HLA system with steroid 21-hydroxylase deficiency has made it possible to diagnose this form of congenital adrenal hyperplasia in utero. This approach is illustrated in a large family at risk for this disorder.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988220     DOI: 10.1007/BF00441576

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  Typing for HLA-D: primed LD typing and homozygous typing cells.

Authors:  F H Bach; E A Valentine; B J Alter; A Svejgaard; M Thomsen
Journal:  Tissue Antigens       Date:  1976-08

2.  Serologically defined HL-A antigens and long-term survival of cadaver kidney transplants. A joint analysis of 918 cases performed by France-Transplant and the London Transplant Group.

Authors:  J Dausset; J Hors; M Busson; H Festenstein; R T Oliver; A M Paris; J A Sachs
Journal:  N Engl J Med       Date:  1974-05-02       Impact factor: 91.245

3.  4th International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of chromosome 6.

Authors: 
Journal:  Cytogenet Cell Genet       Date:  1978

Review 4.  The major histocompatibility complex--genetics and biology. (First of three parts).

Authors:  F H Bach; J J van Rood
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

Review 5.  Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.

Authors:  J A Hansen; R J O'Reilly; R A Good; B Dupont
Journal:  Transplant Proc       Date:  1976-12       Impact factor: 1.066

6.  Detection of HLA-D clusters and segregation studies using primed LD typing.

Authors:  P S Crosier; M Sasportes; C Mawas; D Charmot; J Dausset
Journal:  Tissue Antigens       Date:  1977-10

7.  Primed LD typing: reagent preparation and definition of the HLA-D-region antigens.

Authors:  F H Bach; E K Jarrett-Toh; C J Benike; C Y Shih; E A Valentine; P M Sondel; M L Bach
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

8.  Typing an unrelated panel with PLT cells: association with DW clusters.

Authors:  B J Alter; F H Bach; S Jaramillo; P Wernet
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes.

Authors:  M J Sheehy; P M Sondel; M L Bach; R Wank; F H Bach
Journal:  Science       Date:  1975-06-27       Impact factor: 47.728

10.  Production of HLA antibody in mice immunised with syngeneic mouse-human hybrid cells containing human chromosome 6.

Authors:  D P Aden; R Mausner; B B Knowles
Journal:  Nature       Date:  1978-01-26       Impact factor: 49.962

View more
  2 in total

1.  Discitis--a rare early symptom of ankylosing spondylitis.

Authors:  G Mau; B Helbig; M Mann
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

2.  Lack of association between HLA specificities and Wilms' tumour.

Authors:  K G Evers; P Gutjahr; S Zschiedrich; W Haase; U Knoop
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.